| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. (TPST) has 5 insiders with recent SEC Form 4 filings, including 28 buys and 0 sells. TPST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.6K | $536.5K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2016 | Aldrich Richard | Director | Buy | 59,800 | $9.49 | $567,240.39 | +5.6% | |
| Mar 24, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,800 | $9.49 | $567,240.39 | +5.6% | |
| Mar 22, 2016 | Aldrich Richard | Director | Buy | 59,800 | $10.44 | $624,513.61 | +6.8% | |
| Mar 22, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,800 | $10.44 | $624,513.61 | +6.8% | |
| Mar 18, 2016 | Aldrich Richard | Director | Buy | 59,700 | $8.26 | $492,962.43 | +12.6% | |
| Mar 18, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,700 | $8.26 | $492,962.43 | +12.6% | |
| Mar 16, 2016 | Aldrich Richard | Director | Buy | 59,029 | $7.90 | $466,104.20 | +7.9% | |
| Mar 16, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 59,029 | $7.90 | $466,104.20 | +7.9% | |
| Mar 14, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 162,732 | $7.60 | $1,237,092.00 | +122.6% | |
| Mar 14, 2016 | Aldrich Richard | Director | Buy | 162,732 | $7.60 | $1,237,092.00 | +122.6% |